Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 25630 entries
Sorted by: Best Match Show Resources per page
Evaluation of pyriproxyfen dissemination via Aedes albopictus from a point-source larvicide application in northeast Florida

field stations

Estep AS, Farooq M.
GSID: RmhkoewsgWoJ
AM Lloyd, M Farooq, AS Estep, RD Xue… - Journal of the American …, 2017 - BioOne

The Asian tiger mosquito, Aedes albopictus, ranks among the most important vectors of dengue fever, Zika virus, and chikungunya virus. With no specific medications or vaccines …

Cite
Lloyd, A. M., Farooq, M., Estep, A. S., Xue, R. D., & Kline, D. L. (2017). Evaluation of pyriproxyfen dissemination via Aedes albopictus from a point-source larvicide application in Northeast Florida. Journal of the American Mosquito Control Association, 33(2), 151-155.
Lloyd, Aaron M., et al. "Evaluation of pyriproxyfen dissemination via Aedes albopictus from a point-source larvicide application in Northeast Florida." Journal of the American Mosquito Control Association 33.2 (2017): 151-155.
Copy Download .nbib Format: MLA
Adolescent vaccination strategies: interventions to increase coverage

after-school interventions

[No authors listed]
GSID: 3N2g4L5R1AEJ
CE Lehmann, RC Brady, RO Battley, JL Huggins - Pediatric Drugs, 2016 - Springer

While vaccines have decreased the burden of disease, many adolescents still remain under-immunized, particularly for human papillomavirus (HPV) and influenza. We review the most …

Is it lawful and ethical to prioritize racial minorities for COVID-19 vaccines?

Minority STEM training

Gostin LO, Schmidt H, Williams MA.
GSID: TLyVpezbiXwJ
H Schmidt, LO Gostin, MA Williams - Jama, 2020 - jamanetwork.com

… waiting in line at a health care facility. Second, public health agencies could not provide … through community health centers, many of which serve largely urban minority populations. …

Cite
Schmidt, H., Gostin, L. O., & Williams, M. A. (2020). Is it lawful and ethical to prioritize racial minorities for COVID-19 vaccines?. Jama, 324(20), 2023-2024.
Schmidt, Harald, Lawrence O. Gostin, and Michelle A. Williams. "Is it lawful and ethical to prioritize racial minorities for COVID-19 vaccines?." Jama 324.20 (2020): 2023-2024.
Copy Download .nbib Format: MLA
Health education through analogies: preparation of a community for clinical trials of a vaccine against hookworm in an endemic area of Brazil

Educational trials

[No authors listed]
GSID: SMNapoZJZoUJ
MF Gazzinelli, L Lobato, L Matoso, R Avila… - PLoS neglected …, 2010 - journals.plos.org

… Obtaining informed consent for clinical trials is especially challenging when working in rural, resource-limited areas, where there are often … prepared for clinical trials of experimental hookworm vaccines. This study was conducted to assess whether special educational tools...

Cite
Gazzinelli, M. F., Lobato, L., Matoso, L., Avila, R., de Cassia Marques, R., Shah Brown, A., ... & Diemert, D. J. (2010). Health education through analogies: preparation of a community for clinical trials of a vaccine against hookworm in an endemic area of Brazil. PLoS neglected tropical diseases, 4(7), e749.
Gazzinelli, Maria Flavia, et al. "Health education through analogies: preparation of a community for clinical trials of a vaccine against hookworm in an endemic area of Brazil." PLoS neglected tropical diseases 4.7 (2010): e749.
Copy Download .nbib Format: MLA
Developing AIDS vaccine trials educational programs in Uganda

Educational trials

Kamya M.
GSID: G4zYa3oTCEUJ
JW McGrath, D Mafigiri, M Kamya… - Journal of acquired …, 2001 - europepmc.org

… In preparation for HIV vaccine trials, data on a cohort's knowledge about vaccines and vaccine studies are required so as to tailor educational … This case study highlights the value of incorporating baseline interviews to assess the educational...

Cite
McGrath, J. W., Mafigiri, D., Kamya, M., George, K., Senvewo, R., Svilar, G., ... & Mugisha, E. (2001). Developing AIDS vaccine trials educational programs in Uganda. Journal of acquired immune deficiency syndromes (1999), 26(2), 176-181.
McGrath, Janet W., et al. "Developing AIDS vaccine trials educational programs in Uganda." Journal of acquired immune deficiency syndromes (1999) 26.2 (2001): 176-181.
Copy Download .nbib Format: MLA
Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States

Educational trials

Koblin BA, Heagerty P, Sheon A.
GSID: eN76e8QubQAJ
BA Koblin, P Heagerty, A Sheon, S Buchbinder… - Aids, 1998 - journals.lww.com

… trials, willing to participate in HIV vaccine trials? Estimates of the proportion of high-risk populations willing to participate help determine the feasibility of conducting trials … used to develop educational strategies to improve understanding about vaccines and vaccine...

Cite
Koblin, B. A., Heagerty, P., Sheon, A., Buchbinder, S., Celum, C., Douglas, J. M., ... & Seage, G. (1998). Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. Aids, 12(7), 785-793.
Koblin, Beryl A., et al. "Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States." Aids 12.7 (1998): 785-793.
Copy Download .nbib Format: MLA
Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review

Non-school settings

Bardach A, Ciapponi A.
GSID: 8Ui7LWVEFQ4J
A Ciapponi, A Bardach, A Mazzoni, T Alconada… - medRxiv, 2021 - ncbi.nlm.nih.gov

Background Pregnant women with COVID-19 are at an increased risk of severe COVID-19 illness as well as adverse pregnancy and birth outcomes. Many countries are vaccinating or …

Cite
Ciapponi, A., Bardach, A., Mazzoni, A., Alconada, T., Anderson, S., Argento, F. J., ... & Buekens, P. M. (2021). Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review. medRxiv.
Ciapponi, Agustín, et al. "Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid review." medRxiv (2021).
Copy Download .nbib Format: MLA
Correlates of COVID-19 vaccination status among college students

Latinx/Hispanic ethnicity

Kawaguchi E.
GSID: MxXtLPSTctgJ
M Nicolo, E Kawaguchi, A Ghanem-Uzqueda, AE Kim… - medRxiv, 2021 - medrxiv.org

Objectives. Despite the widespread availability of COVID-19 vaccines in the United States, vaccine hesitancy remains high among certain groups. This study examined the correlates of …

Cite
Nicolo, M., Kawaguchi, E., Ghanem-Uzqueda, A., Kim, A. E., Soto, D., Deva, S., ... & Unger, J. B. (2021). Correlates of COVID-19 vaccination status among college students. medRxiv.
Nicolo, Michele, et al. "Correlates of COVID-19 vaccination status among college students." medRxiv (2021).
Copy Download .nbib Format: MLA
Vaccines: Self-amplifying RNA in lipid nanoparticles: a next-generation vaccine?.

Nature reviews. Drug discovery

Flemming A.
PMID: 23023675
Nat Rev Drug Discov. 2012 Oct;11(10):748-9. doi: 10.1038/nrd3854.

No abstract available.

Cite
Flemming A. Vaccines: Self-amplifying RNA in lipid nanoparticles: a next-generation vaccine?. Nat Rev Drug Discov. 2012;11(10):748-9doi: 10.1038/nrd3854.
Flemming, A. (2012). Vaccines: Self-amplifying RNA in lipid nanoparticles: a next-generation vaccine?. Nature reviews. Drug discovery, 11(10), 748-9. https://doi.org/10.1038/nrd3854
Flemming, Alexandra. "Vaccines: Self-amplifying RNA in lipid nanoparticles: a next-generation vaccine?." Nature reviews. Drug discovery vol. 11,10 (2012): 748-9. doi: https://doi.org/10.1038/nrd3854
Flemming A. Vaccines: Self-amplifying RNA in lipid nanoparticles: a next-generation vaccine?. Nat Rev Drug Discov. 2012 Oct;11(10):748-9. doi: 10.1038/nrd3854. PMID: 23023675.
Copy Download .nbib Format: NLM
A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines.

Genetic vaccines and therapy

Hallengärd D, Bråve A, Isaguliants M, Blomberg P, Enger J, Stout R, King A, Wahren B.
PMID: 22873174
Genet Vaccines Ther. 2012 Aug 08;10(1):5. doi: 10.1186/1479-0556-10-5.

BACKGROUND: The use of optimized delivery devices has been shown to enhance the potency of DNA vaccines. However, further optimization of DNA vaccine delivery is needed for this vaccine modality to ultimately be efficacious in humans.METHODS: Herein we evaluated...

Cite
Hallengärd D, Bråve A, Isaguliants M, et al. A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines. Genet Vaccines Ther. 2012;10(1):5doi: 10.1186/1479-0556-10-5.
Hallengärd, D., Bråve, A., Isaguliants, M., Blomberg, P., Enger, J., Stout, R., King, A., & Wahren, B. (2012). A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines. Genetic vaccines and therapy, 10(1), 5. https://doi.org/10.1186/1479-0556-10-5
Hallengärd, David, et al. "A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines." Genetic vaccines and therapy vol. 10,1 (2012): 5. doi: https://doi.org/10.1186/1479-0556-10-5
Hallengärd D, Bråve A, Isaguliants M, Blomberg P, Enger J, Stout R, King A, Wahren B. A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines. Genet Vaccines Ther. 2012 Aug 08;10(1):5. doi: 10.1186/1479-0556-10-5. PMID: 22873174; PMCID: PMC3532290.
Copy Download .nbib Format: NLM
Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India.

Current therapeutic research, clinical and experimental

Sudarshan MK, Madhusudana SN, Mahendra BJ, Ashwath Narayana DH, Ananda Giri MS, Popova O, Vakil HB.
PMID: 24672132
Curr Ther Res Clin Exp. 2005 Jul;66(4):323-34. doi: 10.1016/j.curtheres.2005.08.009.

BACKGROUND: Human rabies is an ongoing significant public health problem inmany developing countries, with India reporting the highest incidence of rabies-related deaths (∼20,000 per year). Many people living in India cannot afford the standard IM postexposure prophylaxis (PEP) with...

Cite
Sudarshan MK, Madhusudana SN, Mahendra BJ, et al. Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India. Curr Ther Res Clin Exp. 2005;66(4):323-34doi: 10.1016/j.curtheres.2005.08.009.
Sudarshan, M. K., Madhusudana, S. N., Mahendra, B. J., Ashwath Narayana, D. H., Ananda Giri, M. S., Popova, O., & Vakil, H. B. (2005). Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India. Current therapeutic research, clinical and experimental, 66(4), 323-34. https://doi.org/10.1016/j.curtheres.2005.08.009
Sudarshan, M K, et al. "Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India." Current therapeutic research, clinical and experimental vol. 66,4 (2005): 323-34. doi: https://doi.org/10.1016/j.curtheres.2005.08.009
Sudarshan MK, Madhusudana SN, Mahendra BJ, Ashwath Narayana DH, Ananda Giri MS, Popova O, Vakil HB. Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India. Curr Ther Res Clin Exp. 2005 Jul;66(4):323-34. doi: 10.1016/j.curtheres.2005.08.009. PMID: 24672132; PMCID: PMC3964532.
Copy Download .nbib Format: NLM
The role of Peyer's patches in synchronizing gut IgA responses.

Frontiers in immunology

Lycke NY, Bemark M.
PMID: 23181060
Front Immunol. 2012 Nov 07;3:329. doi: 10.3389/fimmu.2012.00329. eCollection 2012.

Because Peyer's patches (PP) are the main inductive sites for gut IgA responses we have focused this review on what we know about the function of PP germinal centers (GC). The vast majority of IgA gene sequences in the...

Cite
Lycke NY, Bemark M. The role of Peyer's patches in synchronizing gut IgA responses. Front Immunol. 2012;3:329doi: 10.3389/fimmu.2012.00329.
Lycke, N. Y., & Bemark, M. (2012). The role of Peyer's patches in synchronizing gut IgA responses. Frontiers in immunology, 3329. https://doi.org/10.3389/fimmu.2012.00329
Lycke, Nils Y, and Bemark, Mats. "The role of Peyer's patches in synchronizing gut IgA responses." Frontiers in immunology vol. 3 (2012): 329. doi: https://doi.org/10.3389/fimmu.2012.00329
Lycke NY, Bemark M. The role of Peyer's patches in synchronizing gut IgA responses. Front Immunol. 2012 Nov 07;3:329. doi: 10.3389/fimmu.2012.00329. eCollection 2012. PMID: 23181060; PMCID: PMC3500999.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 25630 entries